Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Operating Income: 2019-2024

Historic Operating Income for IDEAYA Biosciences (IDYA) over the last 6 years, with Dec 2024 value amounting to -$327.0 million.

  • IDEAYA Biosciences' Operating Income rose 262.13% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$167.5 million, marking a year-over-year increase of 25.47%. This contributed to the annual value of -$327.0 million for FY2024, which is 143.23% down from last year.
  • Latest data reveals that IDEAYA Biosciences reported Operating Income of -$327.0 million as of FY2024, which was down 143.23% from -$134.4 million recorded in FY2023.
  • Over the past 5 years, IDEAYA Biosciences' Operating Income peaked at -$35.3 million during FY2020, and registered a low of -$327.0 million during FY2024.
  • Moreover, its 3-year median value for Operating Income was -$134.4 million (2023), whereas its average is -$174.6 million.
  • Its Operating Income has fluctuated over the past 5 years, first climbed by 20.16% in 2020, then slumped by 143.23% in 2024.
  • IDEAYA Biosciences' Operating Income (Yearly) stood at -$35.3 million in 2020, then tumbled by 42.22% to -$50.3 million in 2021, then fell by 24.34% to -$62.5 million in 2022, then tumbled by 115.08% to -$134.4 million in 2023, then slumped by 143.23% to -$327.0 million in 2024.